Topical tacrolimus for atopic dermatitis.

@article{Martins2015TopicalTF,
  title={Topical tacrolimus for atopic dermatitis.},
  author={Jade Cury Martins and Ciro Martins and Val{\'e}ria Aoki and A{\'e}cio F T G{\'o}is and Henrique Akira Ishii and Edina M K da Silva},
  journal={The Cochrane database of systematic reviews},
  year={2015},
  volume={7},
  pages={CD009864}
}
BACKGROUND Atopic dermatitis (AD) (or atopic eczema) is a chronic inflammatory skin condition that affects children and adults and has an important impact on quality of life. Topical corticosteroids (TCS) are the first-line therapy for this condition; however, they can be associated with significant adverse effects when used chronically. Tacrolimus ointment (in its 2 manufactured strengths of 0.1% and 0.03%) might be an alternative treatment. Tacrolimus, together with pimecrolimus, are drugs… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 24 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 38 references

PUVA Follow up Study. The risk of melanoma in association with long-term exposure to PUVA

  • RS Stern
  • Journal of the American Academy of Dermatology
  • 2001
Highly Influential
3 Excerpts

Efficacy and safety of systemic treatments for moderateto-severe atopic dermatitis: A systematic review

  • E Roekevisch, PI Spuls, D Kuester, J Limpens, J. Schmitt
  • Journal of Allergy & Clinical Immunology
  • 2014

Similar Papers

Loading similar papers…